StoxAcutaas Chemicals vs Krishna Institute of Medical Sciences: share price & financials comparison
NSE: ACUTAAS vs KIMS · Healthcare · as of 06 Nov 2026
Both prices rebased to 100 at the start of the selected period.
Acutaas Chemicals vs Krishna Institute of Medical Sciences at a glance
Acutaas Chemicals (ACUTAAS) has a market capitalisation of ₹31,001 Cr, against ₹30,366 Cr for Krishna Institute of Medical Sciences (KIMS). Over the past year Acutaas Chemicals has returned +124.2%, compared with -1.7% for Krishna Institute of Medical Sciences. On valuation, Acutaas Chemicals trades at a lower P/E of 70.6 versus 143.0. Acutaas Chemicals earns a higher return on equity (23.6% vs 5.4%). Acutaas Chemicals comes out ahead on size, profitability, growth, financial health, momentum and technicals. Krishna Institute of Medical Sciences comes out ahead on valuation. Across the scored metrics below, Acutaas Chemicals leads on 15 and Krishna Institute of Medical Sciences on 2. On StoxGud's 10-point checklist, Acutaas Chemicals scores 9/10 and Krishna Institute of Medical Sciences scores 4/10.
| Metric | Acutaas Chemicals | Krishna Institute of Medical Sciences |
|---|---|---|
| Size | ||
| Market cap | ₹31,001 Cr | ₹30,366 Cr |
| Revenue (latest FY) | ₹1,339 Cr | ₹3,905 Cr |
| Net profit (latest FY) | ₹356 Cr | ₹241 Cr |
| Valuation | ||
| P/E | 70.6 | 143.0 |
| P/B | 16.69 | 7.72 |
| Dividend yield | 0.04% | 0.68% |
| Profitability | ||
| Return on equity | 23.6% | 5.4% |
| Net profit margin | 27.6% | 4.6% |
| Operating margin | 39.1% | 19.3% |
| Growth | ||
| Revenue growth (YoY) | +42.7% | +39.9% |
| Net profit growth (YoY) | +73.3% | +11.8% |
| Revenue CAGR (multi-year) | +26.7% | +24.0% |
| Financial health | ||
| Debt to equity | 0.00 | 0.90 |
| Momentum | ||
| 1-month return | +19.3% | +4.2% |
| 1-year return | +124.2% | -1.7% |
| 3-year CAGR | +87.5% | +24.8% |
| 5-year CAGR | +48.9% | +25.3% |
| Distance from 52W high | -5.4% | -15.0% |
| Technicals | ||
| RSI (14) | 68 | 66 |
| Price vs 200-day avg | +31.9% | -0.7% |
Highlighted cells lead on that metric. Market cap, revenue and RSI are shown for context and not scored.
10-point checklist side by side
| Check | Acutaas Chemicals | Krishna Institute of Medical Sciences |
|---|---|---|
| Price above 50-day average | ✓ | ✗ |
| Price above 200-day average | ✓ | ✗ |
| 50-day average above 200-day (uptrend) | ✓ | ✓ |
| RSI in healthy 40–70 zone | ✓ | ✓ |
| Positive 1-year return | ✓ | ✗ |
| Return on equity above 15% | ✓ | ✗ |
| Debt to equity below 1 | ✓ | ✓ |
| Revenue growing year on year | ✓ | ✓ |
| Net profit margin above 10% | ✓ | ✗ |
| P/E below industry median | ✗ | ✗ |
| Score | 9/10 | 4/10 |
A rules-based screen for education only — not a buy or sell recommendation.
FAQs
Which is bigger, Acutaas Chemicals or Krishna Institute of Medical Sciences?
Acutaas Chemicals has a market cap of ₹31,001 Cr and Krishna Institute of Medical Sciences has a market cap of ₹30,366 Cr as of 06 Nov 2026.
Which has a lower P/E, Acutaas Chemicals or Krishna Institute of Medical Sciences?
Acutaas Chemicals has the lower P/E: Acutaas Chemicals trades at 70.6 and Krishna Institute of Medical Sciences at 143.0.
Which gave better returns in the last year, Acutaas Chemicals or Krishna Institute of Medical Sciences?
Acutaas Chemicals did better: Acutaas Chemicals returned +124.2% and Krishna Institute of Medical Sciences returned -1.7% over one year.
Is Acutaas Chemicals or Krishna Institute of Medical Sciences a better buy?
StoxGud does not give buy or sell recommendations. On our rules-based checklist Acutaas Chemicals scores 9/10 and Krishna Institute of Medical Sciences scores 4/10; compare valuation, profitability, growth and momentum above and consult a SEBI-registered adviser.